Overview


According to FutureWise analysis the market for MRI-guided Neurosurgical Ablation in 2026 is US$ 0.47 billion, and is expected to reach US$ 1.23 billion by 2036 at a CAGR of 10.10%. MRI-guided neurosurgical ablation is a minimally invasive procedure that utilizes real-time imaging to accurately target and destroy abnormal brain tissue, like tumors or epileptic foci. This method improves surgical precision, spares healthy tissue, and shortens recovery compared to traditional surgery. The market is expanding due to the rising use of image-guided therapies, the increasing prevalence of neurological disorders, and advancements in thermal ablation technologies.

MRI-guided neurosurgical ablation is an innovative and minimally invasive technique designed to treat a range of neurological conditions by accurately targeting and eliminating abnormal brain tissue. This method uses real-time magnetic resonance imaging (MRI) to guide the procedure, enhancing the precision of treatment. Through the combination of MRI's advanced imaging capabilities and thermal ablation technologies—such as laser interstitial thermal therapy (LITT)—neurosurgeons can deliver controlled therapy while safeguarding the surrounding healthy brain tissue.

Historically, treating many brain disorders, including tumors, epilepsy, radiation necrosis, and certain movement disorders, often required open craniotomy, a procedure associated with significant risks, longer hospital stays, and extended recovery times. In contrast, MRI-guided ablation involves making a small burr hole to insert a laser probe or ablation catheter, which is then precisely positioned at the targeted site. This allows for the directed application of thermal energy to destroy unhealthy tissue, with MRI thermography providing ongoing feedback to ensure treatment accuracy.

One of the primary benefits of MRI-guided neurosurgical ablation is its capability to access deeply located or surgically challenging brain lesions while minimizing disruption to critical functional areas. Patients typically experience shorter recovery times, less postoperative pain, and reduced complication rates compared to traditional surgical methods. This makes the technique particularly advantageous for high-risk patients or individuals who may not be candidates for open surgery.

With the increasing incidence of brain tumors, drug-resistant epilepsy, and other neurological disorders, the demand for advanced image-guided therapies is on the rise. Technological advancements in MRI systems, thermal monitoring tools, and minimally invasive surgical instruments are broadening the clinical applications of this technique. As the fields of precision medicine and patient-centered care continue to evolve, MRI-guided neurosurgical ablation is emerging as a groundbreaking solution in modern neurosurgery, promising improved patient outcomes and increased treatment precision.

FutureWise Market Research has instantiated a report that provides an intricate analysis of MRI-guided Neurosurgical Ablation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the MRI-guided Neurosurgical Ablation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Siemens Healthineers AG
  • Monteri
  • Profound Medica
  • Insightec
  • Medtronic
  • Boston Scientific Corporation
  • AngioDynamics
  • ClearPoint Neuro, Inc.
  • Elekta
  • Accuray Incorporated

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Products

  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems
  • Accessories

By Treatment Type

  • Brain Metastases
  • Radiation Necrosis
  • Glioma
  • Epilepsy
  • Other Treatments

By End-use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the MRI-guided Neurosurgical Ablation Market By Products, By Treatment Type, By End-use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global MRI-guided Neurosurgical Ablation Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of MRI-guided Neurosurgical Ablation Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global MRI-guided Neurosurgical Ablation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global MRI-guided Neurosurgical Ablation Market, By Products Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. MRI Guided RF Ablation Systems
        2. MRI Guided Laser Ablation Systems
        3. MRI Guided Focused Ultrasound Systems
        4. Accessories

  • 8.   Global MRI-guided Neurosurgical Ablation Market, By Treatment Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Brain Metastases
        2. Radiation Necrosis
        3. Glioma
        4. Epilepsy
        5. Other Treatments

  • 9.  Global MRI-guided Neurosurgical Ablation Market, By End-use Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers

  • 10.   North America MRI-guided Neurosurgical Ablation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America MRI-guided Neurosurgical Ablation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe MRI-guided Neurosurgical Ablation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific MRI-guided Neurosurgical Ablation Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •  1. Siemens Healthineers AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Monteri
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Profound Medica
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Insightec
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medtronic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
            6. Boston Scientific Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AngioDynamics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ClearPoint Neuro, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Elekta
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Accuray Incorporated
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients